NCT06472206Recruiting
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Brief summary (registry, in English)
Although global efforts have been made to end the HIV epidemic, there are still some gaps in HIV testing, antiretroviral therapy (ART) adherence, and viral suppression (VS) among people with HIV (PWH). These gaps are particularly prominent in the Deep South of the United States (US), where PWH face challenges in accessing healthcare services. In response, a team of experienced researchers has developed and tested the Community Health Workers And MHealth to ImProve Viral Suppression (CHAMPS) intervention. This intervention uses mobile health (mHealth) technology and a team of community health workers (CHW) to design an intervention to improve ART adherence and VS. The CHAMPS+ intervention adds a CHW delivered supportive risk reduction counseling during periods of non-suppression to prevent HIV transmission. The study will engage the participants by developing culturally relevant materials and retention strategies, evaluating the clinical effectiveness and sustainability of the intervention in Deep South settings, and assessing regionalized implementation factors. Ultimately, the study will test the effectiveness of CHAMPS+ on ART adherence and viral load suppression for PWH in Alabama, Louisiana, and Mississippi.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 420 (estimated)
- First submitted
- 18 Jun 2024
- Start date
- 23 Sept 2024
- Primary completion date
- 22 Jul 2027
- Lead sponsor
- Columbia University
- Diseases
- HIV
- NCT number
- NCT06472206
What you commit to
- Study type: Interventional
- Planned participants: 420
- From 23 Sept 2024 to the primary completion date, 22 Jul 2027
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment;
Other illness
- Terminal illness with life expectancy \<6 months; and
Other
- Planning to move out of the area in the next 12 months.
Who the study is looking for
- Be able to speak, read, and write in English;
- Be above 18 years of age;
- Be willing to participate in any assigned arm of the intervention;
- Have an HIV-1 RNA level \>200 copies/mL;
- Own a smartphone;
- Be able and willing to provide informed consent for study participation and consent for access to medical records.
- Live, work and or receive care in AL, LA, or MS
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Health Services Center, Inc. Coordinator of this site? Confirm its status | Hobson City | United States | Recruiting |
| University of Mississippi Medical Center Coordinator of this site? Confirm its status | Jackson | United States | Recruiting |
| Tulane University Coordinator of this site? Confirm its status | New Orleans | United States | Recruiting |
| Louisiana State University Health Sciences Center in New Orleans Coordinator of this site? Confirm its status | New Orleans | United States | Recruiting |
| Unity Wellness Center Coordinator of this site? Confirm its status | Opelika | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.